Please check your internet connection and try again.
# Lorazepam
## Overview
Lorazepam is a benzodiazepine medication used for its anxiolytic, sedative, and anticonvulsant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor, resulting in decreased neuronal excitability.
## Primary Indications
* **Anxiety Disorders:** Short-term management of anxiety symptoms.
* **Insomnia:** Short-term treatment of sleep disturbances.
* **Seizure Disorders:** Management of status epilepticus and adjunctive treatment for certain types of seizures.
* **Sedation:** Premedication before surgical procedures or for conscious sedation.
## Adult Dosing
Dosing varies significantly based on indication and patient factors.
* **Anxiety:** Typically 0.5 mg to 2 mg orally 2-3 times daily. Maximum daily dose generally does not exceed 10 mg.
* **Insomnia:** 1 mg to 2 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenously (IV) or intramuscularly (IM) as a single dose. May be repeated after 10-15 minutes if seizures persist, not to exceed 8 mg in a 12-hour period.
* **Premedication:** 2 mg to 4 mg orally or IM 2 hours before surgery. IV administration may be used closer to the procedure.
Dose adjustments should be guided by response and tolerance.
## Pediatric Dosing
Dosing in pediatric populations is less well-established and requires careful consideration due to potential for increased sensitivity and respiratory depression.
* **Status Epilepticus:** 0.05 mg/kg IV/IM (maximum 2 mg per dose). May repeat in 5-10 minutes if needed, not to exceed 0.1 mg/kg total or 4 mg in 12 hours.
* **Sedation/Anxiety:** Dosing is highly individualized, often starting at the lowest effective dose (e.g., 0.02-0.05 mg/kg orally or IV, not to exceed adult doses).
Always consult specific pediatric guidelines or protocols.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; may require dose reduction.
* **Renal Impairment:** Use with caution; may require dose reduction.
* **Elderly:** Start with lower doses (e.g., half of the usual adult dose) and titrate cautiously due to increased sensitivity and risk of CNS effects.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency (relative contraindication, use with extreme caution).
* Sleep apnea.
## Adverse Effects
Common: Sedation, dizziness, weakness, unsteadiness, confusion.
Less Common: Paradoxical excitation, amnesia, depression, respiratory depression (especially with IV administration or in combination with other CNS depressants), hypotension.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Increased risk of profound sedation, respiratory depression, coma, and death.
* **Theophylline/Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproic Acid:** May increase lorazepam plasma concentrations and risk of toxicity.
## Monitoring
* **Respiratory Rate and Depth:** Especially with IV administration or in high-risk patients.
* **Level of Consciousness and Sedation:** Assess for excessive drowsiness or unresponsiveness.
* **Cognitive Function:** Monitor for confusion or memory impairment.
* **Cardiovascular Status:** Blood pressure and heart rate, particularly with IV administration.
* **Signs of Withdrawal:** If used chronically and abruptly discontinued.
## Clinical Pearls
* Lorazepam has an intermediate half-life compared to other benzodiazepines.
* IV lorazepam may precipitate if mixed with certain solutions; administer undiluted or with compatible fluids (e.g., normal saline, D5W).
* Intramuscular absorption can be erratic; IV is preferred for rapid onset in emergencies.
* Avoid abrupt discontinuation after prolonged use to prevent withdrawal symptoms. Tapering is recommended.
* Use lowest effective dose for shortest duration necessary, especially in elderly patients and for anxiety/insomnia.
---
***Disclaimer:** This information is intended for healthcare professionals. Always verify current prescribing information and consult local protocols before making treatment decisions.*
